GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $680,000 | +2.6% | 15,621 | +2.7% | 0.23% | +14.6% |
| Q1 2022 | $663,000 | -1.5% | 15,215 | -0.3% | 0.20% | -1.0% |
| Q4 2021 | $673,000 | +19.5% | 15,267 | +3.7% | 0.20% | +14.3% |
| Q3 2021 | $563,000 | -0.4% | 14,721 | +3.8% | 0.18% | -1.7% |
| Q2 2021 | $565,000 | +20.7% | 14,187 | +8.1% | 0.18% | +12.7% |
| Q1 2021 | $468,000 | +2.9% | 13,125 | +6.1% | 0.16% | -3.1% |
| Q4 2020 | $455,000 | +4.8% | 12,365 | +7.1% | 0.16% | -3.0% |
| Q3 2020 | $434,000 | -9.8% | 11,543 | -2.1% | 0.17% | -16.8% |
| Q2 2020 | $481,000 | +13.7% | 11,790 | +5.5% | 0.20% | +1.5% |
| Q1 2020 | $423,000 | -17.4% | 11,173 | +2.6% | 0.20% | -8.7% |
| Q4 2019 | $512,000 | +7.8% | 10,893 | -2.1% | 0.22% | -4.0% |
| Q3 2019 | $475,000 | +7.0% | 11,124 | +2.6% | 0.23% | +4.6% |
| Q2 2019 | $444,000 | -2.0% | 10,845 | +0.0% | 0.22% | -2.3% |
| Q1 2019 | $453,000 | +8.6% | 10,841 | -0.7% | 0.22% | -1.3% |
| Q4 2018 | $417,000 | – | 10,917 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |